83 related articles for article (PubMed ID: 17191171)
1. Expression profiling of peripheral-blood mononuclear cells from patients with chronic hepatitis C undergoing interferon therapy.
Tateno M; Honda M; Kawamura T; Honda H; Kaneko S
J Infect Dis; 2007 Jan; 195(2):255-67. PubMed ID: 17191171
[TBL] [Abstract][Full Text] [Related]
2. Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C.
Ji X; Cheung R; Cooper S; Li Q; Greenberg HB; He XS
Hepatology; 2003 Mar; 37(3):610-21. PubMed ID: 12601359
[TBL] [Abstract][Full Text] [Related]
3. PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C.
Gerotto M; Dal Pero F; Bortoletto G; Realdon S; Ferrari A; Boccato S; Alberti A
Antivir Ther; 2004 Oct; 9(5):763-70. PubMed ID: 15535414
[TBL] [Abstract][Full Text] [Related]
4. Therapy with interferon-alpha and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells.
Cheng PN; Wei YL; Chang TT; Chen JS; Young KC
J Med Virol; 2008 Jun; 80(6):989-96. PubMed ID: 18428145
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
Asahina Y; Izumi N; Umeda N; Hosokawa T; Ueda K; Doi F; Tsuchiya K; Nakanishi H; Matsunaga K; Kitamura T; Kurosaki M; Uchihara M; Higaki M; Miyake S
J Viral Hepat; 2007 Jun; 14(6):396-403. PubMed ID: 17501760
[TBL] [Abstract][Full Text] [Related]
6. Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C.
Furusyo N; Kubo N; Toyoda K; Takeoka H; Nabeshima S; Murata M; Nakamuta M; Hayashi J
Antiviral Res; 2005 Jul; 67(1):46-54. PubMed ID: 15913800
[TBL] [Abstract][Full Text] [Related]
7. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy.
Taylor MW; Tsukahara T; Brodsky L; Schaley J; Sanda C; Stephens MJ; McClintick JN; Edenberg HJ; Li L; Tavis JE; Howell C; Belle SH
J Virol; 2007 Apr; 81(7):3391-401. PubMed ID: 17267482
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin.
Murakami Y; Nagai A; Kawakami T; Hino K; Kitase A; Hara Y; Okuda M; Okita K; Okita M
Nutrition; 2006 Feb; 22(2):114-22. PubMed ID: 16459223
[TBL] [Abstract][Full Text] [Related]
9. Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C.
Tomimatsu M; Aizawa Y; Chuganji Y; Ishizuka H; Fujita Y; Aizawa R; Abe H; Matsuda T; Itou Y; Nakanishi H; Ushiyama H; Higuchi T; Fujimoto T; Endou H; Iga D; Ohta K; Kuroda H
J Gastroenterol Hepatol; 2006 Jul; 21(7):1177-83. PubMed ID: 16824072
[TBL] [Abstract][Full Text] [Related]
10. Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C.
Marinho RT; Pinto R; Santos ML; Lobos IV; Moura MC
J Viral Hepat; 2004 May; 11(3):206-16. PubMed ID: 15117322
[TBL] [Abstract][Full Text] [Related]
11. Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection.
Goutagny N; Vieux C; Decullier E; Ligeoix B; Epstein A; Trepo C; Couzigou P; Inchauspe G; Bain C
J Infect Dis; 2004 May; 189(9):1646-55. PubMed ID: 15116301
[TBL] [Abstract][Full Text] [Related]
12. Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens.
Schmid M; Kreil A; Jessner W; Homoncik M; Datz C; Gangl A; Ferenci P; Peck-Radosavljevic M
Gut; 2005 Jul; 54(7):1014-20. PubMed ID: 15951552
[TBL] [Abstract][Full Text] [Related]
13. Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV).
Younossi ZM; Limongi D; Stepanova M; Pierobon M; Afendy A; Mehta R; Baranova A; Liotta L; Petricoin E
J Proteome Res; 2011 Feb; 10(2):774-9. PubMed ID: 21204552
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus free-virion and immune-complex dynamics during interferon therapy with and without ribavirin in genotype-1b chronic hepatitis C patients.
Fujita N; Kaito M; Tanaka H; Horiike S; Urawa N; Sugimoto R; Konishi M; Watanabe S; Adachi Y
J Viral Hepat; 2006 Mar; 13(3):190-8. PubMed ID: 16475995
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes.
Meier V; Mihm S; Ramadori G
J Med Virol; 2008 Nov; 80(11):1912-8. PubMed ID: 18814253
[TBL] [Abstract][Full Text] [Related]
16. Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.
Felger JC; Cole SW; Pace TW; Hu F; Woolwine BJ; Doho GH; Raison CL; Miller AH
Psychol Med; 2012 Aug; 42(8):1591-603. PubMed ID: 22152193
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Rizzo G; Barbarini G
Am J Gastroenterol; 1998 Dec; 93(12):2445-51. PubMed ID: 9860407
[TBL] [Abstract][Full Text] [Related]
18. Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.
Tsubota A; Arase Y; Someya T; Suzuki Y; Suzuki F; Saitoh S; Ikeda K; Akuta N; Hosaka T; Kobayashi M; Kumada H
J Med Virol; 2005 Jan; 75(1):27-34. PubMed ID: 15543591
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of interferon-alpha-ribavirin-interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1.
Alric L; Thebault S; Peron JM; Balard P; Metivier S; Pipy B; Izopet J; Vinel JP
J Viral Hepat; 2006 Feb; 13(2):139-44. PubMed ID: 16436132
[TBL] [Abstract][Full Text] [Related]
20. Blood serum glutathione alpha s-transferase (alpha GST) activity during antiviral therapy in patients with chronic hepatitis C.
Mazur W; Gonciarz M; Kajdy M; Mazurek U; Jurzak M; Wilczok T; Gonciarz Z
Med Sci Monit; 2003 Aug; 9 Suppl 3():44-8. PubMed ID: 15156612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
